DEVELOPMENT AND PRODUCTION OF CYTOSTATIC PRODUCTS
About the Proyect
Creating a facility operating on contract manufacturing of cytostatic products and also providing Cuban and foreign entities with the final services of filling and packaging. It must comply with international regulations of agencies such as the Food and Drug Administration (FDA) & the European Medicines Agency (EMA), in order to facilitate sales of the products to Cuban and international clients worldwide.
The facility envisages a manufacturing line of cytostatic products in liquid and lyophilized vials with a capacity for 10 million units per year and a line for cytostatic products in oral doses, with a capacity of 70 million units per year.
Sector:
Pharmaceutical
Modality of Investment:
Joint Venture
Cuban Part:
ENCOMED
Investment Amount:
27 millon USD
Location:
Contact Information
Name:
MSc. Adis Nuvia Neyra Muguercia
Position:
General Director
Email:
adis.nuvia@oc.emcomed.cu
aida.torrens@oc.emcomed.cu
vallin@aica.cu
Phone:
(53) 47863897
(53) 52698188